Clincosm LogoSign in Get a demo

Identification of Biomarkers for Severe Pneumonia

Sponsor
Changhai Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03282383
Collaborator
(none)
600
Enrollment
35.9
Actual Duration (Months)

Study Details

Study Description

Brief Summary

To identify the potential serum biomarkers with regard to the severity of pneumonia, and to further evaluate the prognostic value of these markers.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    First, we will collect serum samples from patients with pneumonia. Then we will identify biomarkers differentially expressed between non-severe pneumonia and severe pneumonia. We will further evaluate the prognostic value of these markers for pneumonia.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    600 participants
    Observational Model:
    Case-Crossover
    Time Perspective:
    Prospective
    Official Title:
    Shanghai Changhai Hospital,Second Military Medical University
    Actual Study Start Date :
    Jan 1, 2014
    Actual Primary Completion Date :
    Dec 30, 2016
    Actual Study Completion Date :
    Dec 30, 2016

    Outcome Measures

    Primary Outcome Measures

    1. microRNA [3 years]

      the all of microRNA of blood plasma

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • under 18 years old
    Exclusion Criteria:
    • over 80 years old

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Changhai Hospital

    Investigators

    • Principal Investigator: Xiangyu Kong, MD, Changhai Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Xiangyu Kong, changhai hospital, Changhai Hospital
    ClinicalTrials.gov Identifier:
    NCT03282383
    Other Study ID Numbers:
    • Severe pneumonia biomarkers
    First Posted:
    Sep 13, 2017
    Last Update Posted:
    Sep 13, 2017
    Last Verified:
    Sep 1, 2017
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Xiangyu Kong, changhai hospital, Changhai Hospital
    biomarkers pneumonia severity
    Additional relevant MeSH terms:
    Pneumonia

    Study Results

    No Results Posted as of Sep 13, 2017